206 related articles for article (PubMed ID: 38747285)
1. Noncanonical WNT5A controls the activation of latent TGF-β to drive fibroblast activation and tissue fibrosis.
Trinh-Minh T; Chen CW; Tran Manh C; Li YN; Zhu H; Zhou X; Chakraborty D; Zhang Y; Rauber S; Dees C; Lin NY; Kah D; Gerum R; Bergmann C; Kreuter A; Reuter C; Groeber-Becker F; Eckes B; Distler O; Fabry B; Ramming A; Schambony A; Schett G; Distler JH
J Clin Invest; 2024 Mar; 134(10):. PubMed ID: 38747285
[TBL] [Abstract][Full Text] [Related]
2. Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-β and WNT7B in Human Lung Fibroblasts.
Newman DR; Sills WS; Hanrahan K; Ziegler A; Tidd KM; Cook E; Sannes PL
J Histochem Cytochem; 2016 Feb; 64(2):99-111. PubMed ID: 26538547
[TBL] [Abstract][Full Text] [Related]
3. Noncanonical Wnt Signaling Promotes Myofibroblast Differentiation in Pulmonary Fibrosis.
Liu T; Gonzalez De Los Santos F; Hirsch M; Wu Z; Phan SH
Am J Respir Cell Mol Biol; 2021 Nov; 65(5):489-499. PubMed ID: 34107237
[TBL] [Abstract][Full Text] [Related]
4. WNT/β-Catenin Signaling Promotes TGF-β-Mediated Activation of Human Cardiac Fibroblasts by Enhancing IL-11 Production.
Działo E; Czepiel M; Tkacz K; Siedlar M; Kania G; Błyszczuk P
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576234
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-β-dependent Wnt secretion controls myofibroblast formation and myocardial fibrosis progression in experimental autoimmune myocarditis.
Blyszczuk P; Müller-Edenborn B; Valenta T; Osto E; Stellato M; Behnke S; Glatz K; Basler K; Lüscher TF; Distler O; Eriksson U; Kania G
Eur Heart J; 2017 May; 38(18):1413-1425. PubMed ID: 27099262
[TBL] [Abstract][Full Text] [Related]
6. WNT-5A regulates TGF-β-related activities in liver fibrosis.
Beljaars L; Daliri S; Dijkhuizen C; Poelstra K; Gosens R
Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G219-G227. PubMed ID: 28057611
[TBL] [Abstract][Full Text] [Related]
7. TGF-β-induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis.
Dees C; Pötter S; Zhang Y; Bergmann C; Zhou X; Luber M; Wohlfahrt T; Karouzakis E; Ramming A; Gelse K; Yoshimura A; Jaenisch R; Distler O; Schett G; Distler JH
J Clin Invest; 2020 May; 130(5):2347-2363. PubMed ID: 31990678
[TBL] [Abstract][Full Text] [Related]
8. Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis.
Palumbo-Zerr K; Zerr P; Distler A; Fliehr J; Mancuso R; Huang J; Mielenz D; Tomcik M; Fürnrohr BG; Scholtysek C; Dees C; Beyer C; Krönke G; Metzger D; Distler O; Schett G; Distler JH
Nat Med; 2015 Feb; 21(2):150-8. PubMed ID: 25581517
[TBL] [Abstract][Full Text] [Related]
9. Cellular and molecular mechanisms in fibrosis.
Dees C; Chakraborty D; Distler JHW
Exp Dermatol; 2021 Jan; 30(1):121-131. PubMed ID: 32931037
[TBL] [Abstract][Full Text] [Related]
10. The Long Noncoding RNA DNM3OS Is a Reservoir of FibromiRs with Major Functions in Lung Fibroblast Response to TGF-β and Pulmonary Fibrosis.
Savary G; Dewaeles E; Diazzi S; Buscot M; Nottet N; Fassy J; Courcot E; Henaoui IS; Lemaire J; Martis N; Van der Hauwaert C; Pons N; Magnone V; Leroy S; Hofman V; Plantier L; Lebrigand K; Paquet A; Lino Cardenas CL; Vassaux G; Hofman P; Günther A; Crestani B; Wallaert B; Rezzonico R; Brousseau T; Glowacki F; Bellusci S; Perrais M; Broly F; Barbry P; Marquette CH; Cauffiez C; Mari B; Pottier N
Am J Respir Crit Care Med; 2019 Jul; 200(2):184-198. PubMed ID: 30964696
[No Abstract] [Full Text] [Related]
11. DOCK2 contributes to pulmonary fibrosis by promoting lung fibroblast to myofibroblast transition.
Guo X; Adeyanju O; Sunil C; Mandlem V; Olajuyin A; Huang S; Chen SY; Idell S; Tucker TA; Qian G
Am J Physiol Cell Physiol; 2022 Jul; 323(1):C133-C144. PubMed ID: 35584329
[TBL] [Abstract][Full Text] [Related]
12. TGF-β activation impairs fibroblast ability to support adult lung epithelial progenitor cell organoid formation.
Ng-Blichfeldt JP; de Jong T; Kortekaas RK; Wu X; Lindner M; Guryev V; Hiemstra PS; Stolk J; Königshoff M; Gosens R
Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L14-L28. PubMed ID: 30969812
[TBL] [Abstract][Full Text] [Related]
13. Bromodomain and Extraterminal (BET) Protein Inhibition Restores Redox Balance and Inhibits Myofibroblast Activation.
Stock CJW; Michaeloudes C; Leoni P; Durham AL; Mumby S; Wells AU; Chung KF; Adcock IM; Renzoni EA; Lindahl GE
Biomed Res Int; 2019; 2019():1484736. PubMed ID: 31119153
[TBL] [Abstract][Full Text] [Related]
14. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
[TBL] [Abstract][Full Text] [Related]
15. Activation of Wnt/β-catenin signalling is required for TGF-β/Smad2/3 signalling during myofibroblast proliferation.
Xu L; Cui WH; Zhou WC; Li DL; Li LC; Zhao P; Mo XT; Zhang Z; Gao J
J Cell Mol Med; 2017 Aug; 21(8):1545-1554. PubMed ID: 28244647
[TBL] [Abstract][Full Text] [Related]
16. WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis.
Vuga LJ; Ben-Yehudah A; Kovkarova-Naumovski E; Oriss T; Gibson KF; Feghali-Bostwick C; Kaminski N
Am J Respir Cell Mol Biol; 2009 Nov; 41(5):583-9. PubMed ID: 19251946
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of latent TGF-β-binding protein 4 affects the fibrotic process in scleroderma by TGF-β/SMAD signaling.
Lu J; Liu Q; Wang L; Tu W; Chu H; Ding W; Jiang S; Ma Y; Shi X; Pu W; Zhou X; Jin L; Wang J; Wu W
Lab Invest; 2017 May; 97(5):591-601. PubMed ID: 28263294
[TBL] [Abstract][Full Text] [Related]
18. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis.
Soare A; Györfi HA; Matei AE; Dees C; Rauber S; Wohlfahrt T; Chen CW; Ludolph I; Horch RE; Bäuerle T; von Hörsten S; Mihai C; Distler O; Ramming A; Schett G; Distler JHW
Arthritis Rheumatol; 2020 Jan; 72(1):137-149. PubMed ID: 31350829
[TBL] [Abstract][Full Text] [Related]
20. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
